CellSource Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3423580004
JPY
397.00
-5 (-1.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

High Management Efficiency with a high ROE of 16.13%

 
2

Company has very low debt and has enough cash to service the debt requirements

 
3

The company has declared Negative results for the last 6 consecutive quarters

4

With ROE of 0.64%, it has a expensive valuation with a 2.28 Price to Book Value

5

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 8,503 Million (Micro Cap)

stock-summary
P/E

357.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.78

stock-summary
Return on Equity

0.84%

stock-summary
Price to Book

1.41

Revenue and Profits:
Net Sales:
971 Million
(Quarterly Results - Apr 2025)
Net Profit:
57 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-18.65%
0%
-18.65%
6 Months
-41.87%
0%
-41.87%
1 Year
-53.4%
0%
-53.4%
2 Years
-71.04%
0%
-71.04%
3 Years
-88.97%
0%
-88.97%
4 Years
-89.57%
0%
-89.57%
5 Years
-87.76%
0%
-87.76%

CellSource Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
18.65%
EBIT Growth (5y)
-173.68%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.72
Sales to Capital Employed (avg)
0.73
Tax Ratio
58.23%
Dividend Payout Ratio
929.37%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
115.51%
ROE (avg)
16.13%

Valuation key factors

Factor
Value
P/E Ratio
357
Industry P/E
Price to Book Value
2.28
EV to EBIT
-66.17
EV to EBITDA
304.89
EV to Capital Employed
5.64
EV to Sales
2.28
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-8.52%
ROE (Latest)
0.64%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Apr'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Apr 2025 is 14.38% vs -16.23% in Jan 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Apr 2025 is 224.40% vs 66.62% in Jan 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Apr'25",
        "Jan'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "971.30",
          "val2": "849.20",
          "chgp": "14.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "125.40",
          "val2": "-9.50",
          "chgp": "1,420.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.30",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.80",
          "val2": "4.40",
          "chgp": "-36.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "56.60",
          "val2": "-45.50",
          "chgp": "224.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "81.60%",
          "val2": "-73.20%",
          "chgp": "15.48%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Oct'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Oct 2024 is -3.45% vs 5.54% in Oct 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Oct 2024 is -74.23% vs -9.30% in Oct 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Oct'24",
        "Oct'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,355.10",
          "val2": "4,510.50",
          "chgp": "-3.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "282.40",
          "val2": "1,287.90",
          "chgp": "-78.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.40",
          "val2": "0.40",
          "chgp": "250.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "10.20",
          "val2": "-16.20",
          "chgp": "162.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "237.90",
          "val2": "923.10",
          "chgp": "-74.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.70%",
          "val2": "270.80%",
          "chgp": "-24.11%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Apr'25 - QoQstock-summary

Apr'25
Jan'25
Change(%)
Net Sales
971.30
849.20
14.38%
Operating Profit (PBDIT) excl Other Income
125.40
-9.50
1,420.00%
Interest
0.30
0.30
Exceptional Items
2.80
4.40
-36.36%
Consolidate Net Profit
56.60
-45.50
224.40%
Operating Profit Margin (Excl OI)
81.60%
-73.20%
15.48%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Apr 2025 is 14.38% vs -16.23% in Jan 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Apr 2025 is 224.40% vs 66.62% in Jan 2025

Annual Results Snapshot (Consolidated) - Oct'24stock-summary

Oct'24
Oct'23
Change(%)
Net Sales
4,355.10
4,510.50
-3.45%
Operating Profit (PBDIT) excl Other Income
282.40
1,287.90
-78.07%
Interest
1.40
0.40
250.00%
Exceptional Items
10.20
-16.20
162.96%
Consolidate Net Profit
237.90
923.10
-74.23%
Operating Profit Margin (Excl OI)
29.70%
270.80%
-24.11%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Oct 2024 is -3.45% vs 5.54% in Oct 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Oct 2024 is -74.23% vs -9.30% in Oct 2023

stock-summaryCompany CV
About CellSource Co., Ltd. stock-summary
stock-summary
CellSource Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available